The development, first reported by the New York Times, further hampers AstraZeneca's efforts in the United States. The government has criticised the drugmaker for using outdated data in the results of its vaccine trial. It later revised its study.
Workers at the Emergent BioSolutions plant several weeks ago conflated ingredients for the J&J and AstraZeneca vaccines, the Times said earlier in the week. J&J said at the time the ruined batch had not advanced to the fill-and-finish stage. The government's move to have the facility make only the J&J single-dose vaccine is meant to avoid future mix-ups, the Times said, citing two senior federal health officials.The top US infectious disease doctor told Reuters on Thursday the country may not need AstraZeneca's vaccine even if it wins approval.
The United States has loan deals to send Mexico and Canada roughly 4 million doses of the AstraZeneca vaccine, made at its US facility.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Risk from COVID-19 variants remains after first Pfizer COVID-19 vaccine, UK study findsLONDON :A single dose of Pfizer's coronavirus vaccine may not generate a sufficient immune response to protect against dominant new variants, ... 所以那些還沒有完成接種第二針疫苗的國家是不能對印度，巴基斯坦，尼泊爾，斯里蘭卡開放的。 3rd and 4th doses coming your way. Then 5th and 6th......... WHILE VIRYS MUTATES
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
US puts Johnson & Johnson in charge of plant that botched Covid-19 vaccine, removes AstraZenecaWASHINGTON — The United States has put Johnson and Johnson in charge of a plant that ruined 15 million doses of its Covid-19 vaccine and has stopped British drugmaker AstraZeneca from using the facility, a senior health official said on Saturday (April 3).
Source: TODAYonline - 🏆 1. / 99 Read more »
COVID-19 vaccine maker AstraZeneca says revenue in first quarter reaches US$275 millionAstraZeneca said on Friday (Apr 30) its COVID-19 vaccine contributed US$275 million in sales and shaved off three cents per share from its ... Good business! Don’t ya just love Big Pharma! Blood sucker
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Mexico looks for US help as AstraZeneca admits Latin American COVID-19 vaccine delayMEXICO CITY :Mexican President Andres Manuel Lopez Obrador said on Friday the United States would probably send his country 5 million more doses ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
India expects biggest share of US doses of AstraZeneca COVID-19 vaccineIndia expects to secure the biggest chunk of the 60 million AstraZeneca COVID-19 vaccine doses that the United States will share globally, two ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »